CTLA4 and colitis: Their study focused on how mechanistic differences between cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) affect colitis, by mapping the FAERS data to the associated molecular pathway and target levels.